文献速递胰腺与胆道疾病

慢性胰腺炎:炎症机制、进展途径与新兴治疗策略

Chronic Pancreatitis: Mechanisms of Inflammation, Pathways of Progression and Emerging Therapeutic Strategies.
PubMed 文献 · Gastroenterology · 2026-04-27

慢性胰腺炎是进行性纤维炎症性疾病,以反复或慢性腹痛及功能不全为特征。其概念模型为腺泡细胞损伤导致炎症和纤维化,诊断通常基于胰管扩张或钙化,早期诊断困难。本综述聚焦炎症机制、早期至晚期进展途径及潜在疾病修饰治疗,提出未来应发展限制炎症、保护器官功能的个体化治疗。

要点

  • 慢性胰腺炎按腺泡损伤-炎症-纤维化模型进展,晚期以胰管扩张或钙化为诊断依据。
  • 早期诊断缺乏经验证的生物标志物且组织病理评估受限,治疗主要针对晚期胰管梗阻。
  • 对早期炎症机制理解有限,阻碍了疾病修饰疗法的开发,未来需个体化抗炎保功能策略。

核心结论

  • 慢性胰腺炎是进行性纤维炎症性疾病,早期炎症机制理解不足阻碍疾病修饰疗法开发,未来应发展限制炎症、保护器官功能的个体化治疗。

研究设计与样本

  • 本文为综述,聚焦慢性胰腺炎的炎症机制、早期至晚期进展途径及当前和新兴治疗策略。

主要发现

  • 慢性胰腺炎遵循腺泡细胞损伤导致炎症和纤维化的概念模型,引起胰腺形态和功能进行性恶化。
  • 诊断通常在胰管扩张或钙化(或两者兼有)时作出,代表疾病晚期;早期诊断因缺乏经验证生物标志物和组织病理评估受限而困难。
  • 当前治疗策略主要针对晚期慢性胰腺炎,通过内镜或手术干预缓解胰管梗阻。
  • 对早期病理生理事件尤其是炎症机制的理解有限,阻碍了预防和延缓疾病进展的疾病修饰疗法开发。

临床怎么用

  • 晚期慢性胰腺炎的治疗以缓解胰管梗阻为目的,可采用内镜或手术干预。
  • 未来应发展个体化治疗策略,以限制炎症并保护器官功能。

局限性

  • 早期慢性胰腺炎诊断缺乏经验证生物标志物且组织病理评估受限。
  • 对早期病理生理事件尤其是炎症机制的理解有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic pancreatitis is a progressive fibroinflammatory disease of the pancreas that causes recurrent or chronic abdominal pain and functional insufficiency. Chronic pancreatitis follows the conceptual model of acinar cell injury, which leads to inflammation and finally fibrosis, resulting in progressively worsening morphologic and functional changes in the pancreas. The diagnosis is generally made in the presence of pancreatic duct dilatation or calcification, or both, which represents an advanced form of the disease. The diagnosis of the early stage of the disease remains challenging due to a lack of validated biomarkers and limited access to histopathologic assessment. Thus, the current treatment strategy primarily focuses on relieving pancreatic ductal obstruction via endoscopic or surgical intervention in advanced chronic pancreatitis. Our understanding of the early pathophysiological events, particularly the mechanisms of inflammation, is limited. This has hampered progress in developing disease-modifying therapies to prevent and retard disease progression. This review focuses on mechanisms of inflammation, pathways of progression from early- to late-stage disease, and current and emerging therapies with the potential to modify the clinical trajectory of chronic pancreatitis. A patient-tailored approach to therapy that limits inflammation and preserves organ function should be developed in the future.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Mahapatra SJ, Chowdhury SD, Akshintala VS, et al. Chronic Pancreatitis: Mechanisms of Inflammation, Pathways of Progression and Emerging Therapeutic Strategies. Gastroenterology. 2026. PMID: 42055197. doi:10.1053/j.gastro.2026.03.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。